Stocktoria
PRECISION BIOSCIENCES INC DTIL
PRECISION BIOSCIENCES INC financials (annual)
Bars are annual figures from 2018 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $34.3M | $68.7M | $48.7M | $25.1M | $115.5M | $24.3M | $1.1B | $10.9M |
| R&D expense | $54.2M | $59.6M | $53.4M | $46.1M | $115.2M | $98.1M | $82.4M | $45.1M |
| Operating income | -$52.1M | -$26.2M | -$43.7M | -$62.3M | -$39.4M | -$109.8M | -$87.2M | -$47.9M |
| Interest expense | — | $1.8M | $2.2M | $1.1M | $132,000 | — | $182,000 | — |
| Income tax | $0 | $0 | — | — | — | $23,000 | — | — |
| Net income | -$45.7M | $7.2M | -$61.3M | -$111.6M | -$30.6M | -$109.0M | -$92.9M | -$46.0M |
| EPS (diluted) | $-3.56 | $1.04 | $-15.96 | $-38.10 | $-0.52 | — | — | — |
| Operating cash flow | -$65.8M | -$58.4M | -$84.1M | -$45.8M | -$10.9M | -$87.4M | -$71.0M | -$51.7M |
| Cash & equivalents | $110.8M | $85.9M | $116.7M | $189.6M | $143.7M | $89.8M | $180.9M | $103.2M |
| Total assets | $154.4M | $136.4M | $159.8M | $238.2M | $211.5M | $150.2M | $235.2M | $138.6M |
| Total liabilities | $62.2M | $80.0M | $140.9M | $177.7M | $120.3M | $105.7M | $96.9M | $98.6M |
| Shareholders' equity | $92.2M | $56.4M | $18.9M | $60.4M | $91.2M | $44.4M | $138.3M | $40.0M |
Growth · year-over-year · Revenue CAGR 17.8%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue growth | -50.1% | +41.0% | +94.1% | -78.3% | +375.7% | -97.7% | +9731.8% | — |
| Net income growth | -738.0% | — | — | — | — | — | — | — |
| EPS growth | -442.3% | — | — | — | — | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.